In mast cells, cross-linking the high-affinity IgE receptor (FcϵRI) initiates the Lyn-mediated phosphorylation of receptor ITAMs, forming phospho-ITAM binding sites for Syk. Previous immunogold labeling of membrane sheets showed that resting FcϵRI colocalize loosely with Lyn, whereas cross-linked FcϵRI redistribute into specialized domains (osmiophilic patches) that exclude Lyn, accumulate Syk, and are often bordered by coated pits. Here, the distribution of FcϵRI β is mapped relative to linker for activation of T cells (LAT), Grb2-binding protein 2 (Gab2), two PLCγ isoforms, and the p85 subunit of phosphatidylinositol 3-kinase (PI3-kinase), all implicated in the remodeling of membrane inositol phospholipids. Before activation, PLCγ1 and Gab2 are not strongly membrane associated, LAT occurs in small membrane clusters separate from receptor, and PLCγ2, that coprecipitates with LAT, occurs in clusters and along cytoskeletal cables. After activation, PLCγ2, Gab2, and a portion of p85 colocalize with FcϵRI β in osmiophilic patches. LAT clusters enlarge within 30 s of receptor activation, forming elongated complexes that can intersect osmiophilic patches without mixing. PLCγ1 and another portion of p85 associate preferentially with activated LAT. Supporting multiple distributions of PI3-kinase, FcϵRI cross-linking increases PI3-kinase activity in anti-LAT, anti-FcεRIβ, and anti-Gab2 immune complexes. We propose that activated mast cells propagate signals from primary domains organized around FcεRIβ and from secondary domains, including one organized around LAT.
Skip Nav Destination
Article navigation
6 August 2001
Article|
August 06 2001
High resolution mapping of mast cell membranes reveals primary and secondary domains of FcϵRI and LAT
Bridget S. Wilson,
Bridget S. Wilson
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Search for other works by this author on:
Janet R. Pfeiffer,
Janet R. Pfeiffer
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Search for other works by this author on:
Zurab Surviladze,
Zurab Surviladze
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Search for other works by this author on:
Elizabeth A. Gaudet,
Elizabeth A. Gaudet
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Search for other works by this author on:
Janet M. Oliver
Janet M. Oliver
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Search for other works by this author on:
Bridget S. Wilson
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Janet R. Pfeiffer
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Zurab Surviladze
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Elizabeth A. Gaudet
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Janet M. Oliver
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Address correspondence to Bridget S. Wilson, Department of Pathology, University of New Mexico Health Sciences Center, CRF 205, 2325 Camino de Salud, Albuquerque, NM 87131. Tel.: (505) 272-8852. Fax: (505) 272-1435. E-mail [email protected]
*
Abbreviations used in this paper: DNP-BSA, dinitrophenol-conjugated BSA; FcϵRI, high-affinity IgE receptor; Gab2, Grb2-binding protein 2; LAT, linker for activation of T cells; PI3-kinase, phosphatidylinositol 3-kinase; PtdIns(3,4,5)P3, phosphatidylinositol 3,4,5-triphosphate; RBL-2H3, rat basophilic leukemia cell line 2H3.
Received:
April 12 2001
Revision Received:
June 27 2001
Accepted:
July 02 2001
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2001
J Cell Biol (2001) 154 (3): 645–658.
Article history
Received:
April 12 2001
Revision Received:
June 27 2001
Accepted:
July 02 2001
Citation
Bridget S. Wilson, Janet R. Pfeiffer, Zurab Surviladze, Elizabeth A. Gaudet, Janet M. Oliver; High resolution mapping of mast cell membranes reveals primary and secondary domains of FcϵRI and LAT . J Cell Biol 6 August 2001; 154 (3): 645–658. doi: https://doi.org/10.1083/jcb.200104049
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement